Inhibition of mammalian target of rapamycin (mTOR) signaling has been shown to potentiate the effects of ATRA and ATO to induce growth arrest and differentiation of APL (NB4) and AML cells in vitro and in vivo models [51, 52]. Here, MTOR is linked to acute myeloid leukemia.